Clinical Trial Detail

NCT ID NCT02530437
Title A Phase 1B/2 Study of LY2940680 in Combination With Weekly Paclitaxel, Carboplatin, and Radiation in Localized Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

Therapies

Taladegib

Carboplatin + Paclitaxel

Age Groups: adult

No variant requirements are available.